Evidence map›Paper›PMID 31380846›Full record

ArticleJournal of visualized experiments : JoVE2019

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease.

Virginia Wertman, Anastasia Gromova, Albert R La Spada, Constanza J Cortes

Registry-linked trialOpen access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05855577 (-Clinical Efficacy of Pharmacological Treatments Targeting Energy Metabolism, Evaluated by Gait Analysis, on Motor Function in Parkinson's Disease Patients), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05855577 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

-Clinical Efficacy of Pharmacological Treatments Targeting Energy Metabolism, Evaluated by Gait Analysis, on Motor Function in Parkinson's Disease Patients

TypeinterventionalSponsorI.R.C.C.S. Fondazione Santa LuciaRan2023 to 2026Enrolled50ConditionsParkinson Disease, Gait Analysis, Therapy, Directly Observed, Metabolic DiseaseArmsTerazosin
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Autophagy · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Behavioral decline in Shank3Molecular autism · 2024
    Article
  17. Article
  18. Behavioral regression in shank3Research square · 2024
    Article
  19. Article
  20. Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Virginia WertmanDepartment of Neurology, Duke University School of Medicine; Duke Center for Neurodegeneration & Neurotherapeutics, Duke University School of Medicine.
Anastasia GromovaDepartment of Neurology, Duke University School of Medicine; Duke Center for Neurodegeneration & Neurotherapeutics, Duke University School of Medicine; Biomedical Sciences Graduate Program, University of California San Diego.
Albert R La SpadaDepartment of Neurology, Duke University School of Medicine; Duke Center for Neurodegeneration & Neurotherapeutics, Duke University School of Medicine; Department of Neurobiology, Duke University School of Medicine; Department of Cell Biology, Duke University School of Medicine.
Constanza J CortesDepartment of Neurology, Duke University School of Medicine; Duke Center for Neurodegeneration & Neurotherapeutics, Duke University School of Medicine; constanza.cortes@duke.edu.
Duke University · US

Funding

MODELS OF SBMA MOTOR NEURON DEGENERATIONR01NS041648 · NINDS · UNIVERSITY OF WASHINGTON · PI LA SPADA, ALBERT R · 2001 to 2014
$4.5M
Enhanced skeletal muscle proteostasis as a determinant of CNS protein quality control and neural function in the aging brainRF1AG057264 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CORTES, CONSTANZA JAVIERA, LA SPADA, ALBERT R · 2017 to 2021
$2.7M
Deconstructing the cellular and molecular basis of SBMA motor neuron disease: From mechanism to therapyR01NS100023 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LA SPADA, ALBERT R · 2016 to 2020
$2.4M
Enhanced Skeletal Muscle Proteostasis as a Modulator of Alzheimer's DiseaseR03AG063215 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CORTES, CONSTANZA JAVIERA · 2019 to 2020
$309k
NIA NIH HHS R03 AG063215NIA NIH HHS RF1 AG057264NINDS NIH HHS R01 NS041648NINDS NIH HHS R01 NS100023
6 · The paper itself

Abstract

Measurement of animal locomotion is a common behavioral tool used to describe the phenotype of a given disease, injury, or drug model. The low-cost method of gait analysis demonstrated here is a simple but effective measure of gait abnormalities in murine models. Footprints are analyzed by painting a mouse's feet with non-toxic washable paint and allowing the subject to walk through a tunnel on a sheet of paper. The design of the testing tunnel takes advantage of natural mouse behavior and their affinity for small dark places. The stride length, stride width, and toe spread of each mouse is easily measured using a ruler and a pencil. This is a well-established and reliable method, and it generates several metrics that are analogous to digital systems. This approach is sensitive enough to detect changes in stride early in phenotype presentation, and due to its non-invasive approach, it allows for testing of groups across life-span or phenotypic presentation.

Indexed as

Behavior, AnimalCosts and Cost AnalysisPhenotypeAnimalsDisease Models, AnimalFemaleGait AnalysisHumansMaleMiceNeuromuscular DiseasesWalking

Identifiers

PMID31380846
PMCPMC7553151
OpenAlexW2961371271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.